HIF-1α-regulated lncRNA-TUG1 promotes mitochondrial dysfunction and pyroptosis by directly binding to FUS in myocardial infarction
Pyroptosis
Terminal deoxynucleotidyl transferase
Creatine kinase
DOI:
10.1038/s41420-022-00969-8
Publication Date:
2022-04-08T06:10:28Z
AUTHORS (12)
ABSTRACT
Myocardial infarction (MI) is a fatal heart disease that affects millions of lives worldwide each year. This study investigated the roles HIF-1α/lncRNA-TUG1 in mitochondrial dysfunction and pyroptosis MI. CCK-8, DHE, lactate dehydrogenase (LDH) assays, JC-1 staining were performed to measure proliferation, reactive oxygen species (ROS), LDH leakage, damage hypoxia/reoxygenation (H/R)-treated cardiomyocytes. Enzyme-linked immunoassay (ELISA) flow cytometry used detect LDH, creatine kinase (CK), its isoenzyme (CK-MB) levels caspase-1 activity. Chromatin immunoprecipitation (ChIP), luciferase assay, RNA-immunoprecipitation (RIP) assess interaction between HIF-1α, TUG1, FUS. Quantitative real-time polymerase chain reaction (qRT-PCR), Western blotting, immunohistochemistry TUG1 pyroptosis-related molecules. Hematoxylin eosin (HE), 2,3,5-triphenyltetrazolium chloride (TTC), terminal deoxynucleotidyl transferase dUTP risk end labelling (TUNEL) employed examine morphology, area, myocardial injury MI mouse model. Mitochondrial induced H/R-treated cardiomyocytes, accompanied by an increase expression HIF-α TUG1. HIF-1α promoted directly binding promoter. silencing inhibited H/R-induced ROS production, proteins NLRP3, GSDMD. Additionally, H/R elevated FUS which silencing. Fused sarcoma (FUS) overexpression reversed effect on activation. However, inhibitor N-acetylcysteine (NAC) protective knockdown cardiomyocyte damage. The vivo model showed increased infarction, injury, pyroptosis, targeting upregulated promotes combining with FUS, thereby promoting occurrence HIF-1α/TUG1/FUS may serve as potential treatment target for
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (41)
CITATIONS (40)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....